The Health Care M&A Monthly: Drug Deals Dominate M&A–
Biotech And Pharma Outspend All Other Sectors Email this article to a friend Email Editor Rarely have we seen a month in the health care merger and acquisition market where the financial results were as lopsided as May’s. Based on figures currently available, the...The Health Care M&A Monthly: CVS and Caremark Rx to Combine- Is This $21.0
Fifteen Deals Worth $7.8 Billion Announced in October Email Editor The month of October recorded a combined total of 15 mergers and acquisitions in the Biotechnology sector. This represents one-third of the 45 health care technology deals reported during the month,...The SeniorCare Investor: Assisted Living Concepts Public
AdCare Health Systems Also Completes Its Small IPO Although there were questions about whether to proceed with the proposed restructuring of Extendicare Inc., including the spin-off of Assisted Living Concepts (NYSE: ALC) into a separate publicly traded company, as...The SeniorCare Investor: Peak, Plateau or More?
A Bipolar Market Tries To Figure Out What’s Next Email Editor It is generally agreed that the entire senior care market hit rock bottom in 2003, most likely in the summer, after overbuilding and over-leverage almost killed the assisted living industry, and...The SeniorCare Investor: Carlyle Wins Manor Care Bid
Its Size Will Only Be Topped By The Sale Of Holiday When Manor Care (NYSE: HCR) announced in April that it had hired JPMorgan to look at the company’s “strategic alternatives,” the shares shot up in value by 11%, which came on top of a 19% increase in...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
